We are pleased to announce the publication of our review article titled “Present Scenario and Future Landscape of Payloads for ADCs: Focus on DNA-Interacting Agents” in Pharmaceuticals, as part of the Special Issue “Evaluation of the Antitumor Mechanism of Armed Antibodies: 2nd Edition“.
This paper explores the latest advances in the use of DNA-interacting agents as payloads for antibody-drug conjugates (ADCs). It offers valuable insights into how these agents can be optimized for the development of more effective and safer therapeutic options for patients.
